Latest Financials News

Brisbane Broncos Limited revealed solid financial results and operational growth for 2024 at their 2025 Annual General Meeting, highlighting record membership and commercial gains alongside strategic investments.

Despite a tough 2024 NRL season for the men's team, Brisbane Broncos delivered record memberships, increased attendance, and a solid financial performance with a $5.7 million profit.

Atomo Diagnostics has released a Target Market Determination for a new capital raising involving options and shares, including a $1 million Share Purchase Plan and placement offer. The move targets eligible Australian shareholders and aims to bolster the company’s financial position amid a speculative investment environment.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.

Andromeda Metals has successfully raised $5 million through a share placement to institutional investors, aiming to accelerate development of its Great White and HPA projects. The company also plans to issue options that could inject further capital if exercised.

Dotz Nano Limited has announced a A$1.2 million private placement at a discounted share price, accompanied by options, to bolster working capital and support the commercialisation of its carbon capture technology.

OFX Limited reported a resilient FY25 with steady revenue and strong cash flow, while advancing its New Client Platform and strategic market expansion despite economic headwinds.

OFX Group reported a slight revenue decline in FY25 but is doubling down on its New Client Platform rollout to drive future growth and diversify revenue streams.

OFX Group Limited posted a 3.4% drop in revenue for FY25, with profits falling over 18%, while continuing its active share buy-back strategy.

Kogan.com Ltd reports robust sales and profit growth for the first four months of 2025, powered by strong marketing investment, while its subsidiary Mighty Ape faces technical setbacks but shows early signs of recovery.

Sayona Mining reports solid FY25 operational gains and outlines strategic merger progress with Piedmont Lithium, positioning itself as a leading North American lithium producer amid a recovering market.

Avecho Biotechnology has expanded its pivotal Phase III clinical trial for a CBD insomnia treatment by adding new recruitment sites and partnering with pharmaceutical giant Sandoz to boost patient enrolment and regulatory progress.